HIV Vaccines

U.S. Firm Begins Test of Vaccine in Thailand

Published in Medical Letter on the CDC and FDA, February 22nd, 1999

U.S. researchers said they had permission to begin an advanced trial of an HIV vaccine in Thailand.

VaxGen Inc., Brisbane, California, said 2,500 Thais at high risk for HIV would be recruited for the trial of the AIDSVAX vaccine, which has been tailored to work against the strain of HIV seen most commonly in Asia.

"This is the next step around the world," said Dr. Donald Francis, VaxGen and former director of the U.S. Centers for Disease Control and Prevention's (CDC) AIDS efforts. "No one can ignore 16,000 new infections a day of a virus that has essentially 100 percent mortality, and the only way it's going to be stopped is a vaccine. Everyone in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1999-02-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry